Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. MU
4. SPY
5. META
6. ABVX
7. NVDA
8. BE
9. SPCX
10. STZ

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
(NASDAQ: CRVS) Delayed: 14.76 -0.18 (1.2%)
Previous Close $14.94    52 Week High $17.77 
Open $14.84    52 Week Low $9.63 
Day High $15.86    P/E N/A 
Day Low $14.66    EPS $0.00 
Volume 2,088,648